Log in to save to my catalogue

De novo NAD+ biosynthetic impairment in acute kidney injury in humans

De novo NAD+ biosynthetic impairment in acute kidney injury in humans

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6129212

De novo NAD+ biosynthetic impairment in acute kidney injury in humans

About this item

Full title

De novo NAD+ biosynthetic impairment in acute kidney injury in humans

Publisher

New York: Nature Publishing Group US

Journal title

Nature medicine, 2018-09, Vol.24 (9), p.1351-1359

Language

English

Formats

Publication information

Publisher

New York: Nature Publishing Group US

More information

Scope and Contents

Contents

Nicotinamide adenine dinucleotide (NAD
+
) extends longevity in experimental organisms, raising interest in its impact on human health. De novo NAD
+
biosynthesis from tryptophan is evolutionarily conserved yet considered supplanted among higher species by biosynthesis from nicotinamide (NAM). Here we show that a bottleneck enzyme in de...

Alternative Titles

Full title

De novo NAD+ biosynthetic impairment in acute kidney injury in humans

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6129212

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6129212

Other Identifiers

ISSN

1078-8956

E-ISSN

1546-170X

DOI

10.1038/s41591-018-0138-z

How to access this item